01.04.2026 19:10 | The Guardian World
FDA planned to fast-track applications for authorization, but agency reviewers raise alarm over addiction riskPopular nicotine pouch products have yet to be cleared for sale in the United States despite a fast-track Food and Drug Administration scheme, as agency scientists hesitate to authorize them due to potential risks to new users, including children, three sources told Reuters.New tobacco products like pouches, which users insert under their lip to get a nicotine buzz, must be authorised by the FDA in order to be legally sold in the US, the world’s largest market for smoking alternatives worth some $22bn. Continue reading...
🔗 Citește articolul complet pe The Guardian World18.10.2026 18:34 | Antena 3 CNN
18.10.2026 18:32 | Prosport
18.10.2026 18:32 | G4Media
18.10.2026 18:29 | Gazeta Sporturilor
18.10.2026 18:28 | Sport.ro
18.10.2026 18:28 | HotNews